ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In an ...
Management reaffirmed organic revenue growth guidance of mid-single digits for Q3 and high single digits by Q4. Improvement is expected in China, driven by stimulus programs and increased government ...
In trading on Monday, shares of Bio-Techne Corp (Symbol: TECH) crossed above their 200 day moving average of $73.66, changing hands as high as $74.93 per share. Bio-Techne Corp shares are currently ...
Bio-Techne outlines 2025 growth drivers with NIH uncertainty and strong Protein Sciences performance
Management expects growth momentum to slow to low-single digits in Q4 due to uncertainties around NIH funding and tariffs. Adjusted operating margin is projected to be 100 to 150 basis points lower in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback